covid 19 News and Research

RSS

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

A new study has revealed that ATV006, which is a 5′-hydroxyl-isobutyryl prodrug, possesses extraordinary oral pharmaco-kinetic (PK) profiles in rats and cynomolgus monkeys and exhibited significant antiviral activity against ancestral SARS-COV-2 strain as well as VOCs.

20 May 2022

The link between androgens and COVID-19

A new paper examines the association between androgens and COVID-19, as revealed by the research carried out on this topic throughout the pandemic.

20 May 2022

Study explores if prior infection with SARS-CoV-2 increased sensitivity to a mitochondrial toxin known to induce parkinsonism

The authors of the current study looked at the potential for an increased risk of parkinsonism following a bout of SARS-CoV-2 infection through accepted post-viral mechanisms.

20 May 2022

Study tests whether the political climate in each US state and Washington, DC determined the nature of the spread of COVID-19 cases and deaths during 2020

Researchers assessed the association of the spread of coronavirus disease 2019 (COVID-19) with the political climate in the US in 2020.

20 May 2022

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

One in five multi-drug resistant (MDR) tuberculosis (TB) cases in children under the age of 15 could be averted every year by household contact management, according to a new modeling study published in The Lancet Global Health.

20 May 2022

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

Investigators demonstrated S100A9 as an inflammatory biomarker among hospitalized SARS-CoV-2 patients.

20 May 2022

A step-by-step plan to create a digital twin of the human immune system

An article published May 20 in Nature Digital Medicine provides a step-by-step plan for an international effort to create a digital twin of the human immune system.

20 May 2022

Serologic response to SARS-CoV-2 may predict COVID-19 severity

A new study reported that antibody titers against SARS-CoV-2 could serve as a marker for the severity of COVID-19.

20 May 2022

High-tech’s business model hasn’t worked for the cue covid test

"I've got this," coos Gal Gadot in Cue Health's Super Bowl TV commercial. Cue hired the "Wonder Woman" actress to be the voice of the company's new high-tech covid-19 testing device.

20 May 2022

Identification of long COVID patients through machine learning

Researchers developed a machine learning approach to identify patients with long coronavirus disease.

20 May 2022

Exploring cross-neutralizing anti-SARS-CoV-2 antibody responses among the general population

Researchers performed a molecular analysis of cross-reactive antibodies targeted against the receptor-binding domain of SARS-CoV-2 strains among the general population.

20 May 2022

Scientists explore mortality among women on hormone replacement therapy early in COVID-19 pandemic

A new study assessed the association of hormone replacement therapy or the use of the combined oral contraceptive pill with mortality among women with a previous history of COVID-19.

20 May 2022

Ensitrelvir demonstrates swift SARS-CoV-2 clearance and safety among individuals with asymptomatic, mild, or moderate SARS-CoV-2 infections

Researchers reported findings that assessed the safety and efficacy of Ensitrelvir among patients with asymptomatic or mild-to-moderate SARS-CoV-2 infection in Japan.

20 May 2022

Evaluating the safety of COVID-19 vaccines in younger children

Researchers investigated the safety of COVID-19 vaccines in children in the US.

20 May 2022

The enigma of post-acute infection syndromes

In a recent review published in the journal Nature Medicine, researchers summarized known literature findings of the unexplained post-acute infection syndromes (PAISs).

20 May 2022

Natural immunity weak and short-lived in unvaccinated after Omicron infection

In a recent study posted to the journal Nature, researchers showed that the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron infection without SARS-CoV-2 vaccination conferred poor cross-variant neutralizing capacities.

20 May 2022

Parental hesitancy and childhood COVID vaccination

A recent article under review at Nature Portfolio and posted to the Research Square* preprint server explored the opinions of adults on vaccinating children against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

20 May 2022

Comparison of COVID-induced ARDS and sepsis-induced ARDS

In a recent study posted to the medRxiv* preprint server, researchers compared the pathophysiology of coronavirus disease 2019 (COVID-19) and bacterial sepsis-induced acute respiratory distress syndrome (ARDS).

20 May 2022

COVID-19's impact on sex and fertility

The potential effects of SARS-CoV-2 on sexual activity and fertility.

20 May 2022

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

How does the immune system remember and recognize viral invaders it has encountered in the past? A trio of newly published studies of people infected with SARS-CoV-2, vaccinated against the virus or both, are providing tantalizing new clues about the factors that influence the speed and magnitude of the immune system's response to subsequent infection with variants of SARS-CoV-2.

19 May 2022

covid 19 News and Research

Study demonstrates that ATV006 is orally bioavailable and has potent efficacy against SARS-CoV-2

The link between androgens and COVID-19

Study explores if prior infection with SARS-CoV-2 increased sensitivity to a mitochondrial toxin known to induce parkinsonism

Study tests whether the political climate in each US state and Washington, DC determined the nature of the spread of COVID-19 cases and deaths during 2020

Household contact management could help avert 20% of the multi-drug resistant TB cases in children

Evaluating serum levels of S100A9 as an inflammatory marker of unfavorable outcomes in patients with COVID-19

A step-by-step plan to create a digital twin of the human immune system

Serologic response to SARS-CoV-2 may predict COVID-19 severity

High-tech’s business model hasn’t worked for the cue covid test

Identification of long COVID patients through machine learning

Exploring cross-neutralizing anti-SARS-CoV-2 antibody responses among the general population

Scientists explore mortality among women on hormone replacement therapy early in COVID-19 pandemic

Ensitrelvir demonstrates swift SARS-CoV-2 clearance and safety among individuals with asymptomatic, mild, or moderate SARS-CoV-2 infections

Evaluating the safety of COVID-19 vaccines in younger children

The enigma of post-acute infection syndromes

Natural immunity weak and short-lived in unvaccinated after Omicron infection

Parental hesitancy and childhood COVID vaccination

Comparison of COVID-induced ARDS and sepsis-induced ARDS

COVID-19's impact on sex and fertility

Studies provide insight into how long COVID-19 immunity lasts and nature of immune recall

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest News